Form 4: VICOR Director Sells Shares Under 10b5-1 Plan
Insider Transaction Report
VICOR CORP Director Andrew D'Amico executed multiple stock option exercises and subsequent sales of common stock on October 22-23, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- Director Andrew D'Amico, a director of VICOR CORP, engaged in multiple transactions involving the company's common stock.
- Transactions occurred on October 22, 2025, and October 23, 2025.
- All sales were conducted pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2024.
- Exercised a total of 15,242 non-qualified stock options and immediately sold the underlying common stock.
- Option exercise prices ranged from $25.30 to $75.43 per share.
- Common stock sale prices ranged from $80.00 to $90.00 per share.
- Following these transactions, Andrew D'Amico's direct beneficial ownership of common stock for the reported transactions became 0 shares.
Sentiment
Score: 6
Explanation: The transactions represent a director exercising stock options and selling the acquired shares under a pre-arranged 10b5-1 trading plan. While a director selling shares can sometimes be viewed negatively, the existence of a 10b5-1 plan mitigates concerns about opportunistic insider selling, suggesting a planned liquidity event rather than a reaction to new negative information.
Positives
- The sales were executed under a pre-arranged Rule 10b5-1 trading plan, which indicates the transactions were scheduled in advance and not based on immediate, undisclosed material information.
Negatives
- A director selling a significant number of shares, even under a 10b5-1 plan, could be perceived by some investors as a reduction in insider conviction, although this is a common liquidity event for executives.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: May observe the director's sale as a liquidity event, potentially influencing sentiment, though the 10b5-1 plan suggests it is a routine, pre-planned transaction.
Key Dates
| Date | Description |
|---|---|
| 03/26/2023 | Date when some Non Qualified Stock Options became exercisable. |
| 09/12/2024 | Date Rule 10b5-1 trading plan was adopted by the reporting person. |
| 04/25/2024 | Date when some Non Qualified Stock Options became exercisable. |
| 04/25/2025 | Date when some Non Qualified Stock Options became exercisable. |
| 05/02/2025 | Date when some Non Qualified Stock Options became exercisable. |
| 05/12/2025 | Date when some Non Qualified Stock Options became exercisable. |
| 06/24/2025 | Date when some Non Qualified Stock Options became exercisable. |
| 10/22/2025 | Date of multiple stock option exercises and subsequent sales of common stock. |
| 10/23/2025 | Date of additional stock option exercises and subsequent sales of common stock. |
| 10/24/2025 | Date the Form 4 was signed and filed. |
| 03/26/2028 | Expiration date for some Non Qualified Stock Options. |
| 04/25/2029 | Expiration date for some Non Qualified Stock Options. |
| 06/24/2032 | Expiration date for some Non Qualified Stock Options. |
Recommendation
holdThe filing details routine insider transactions (option exercises and sales) conducted under a pre-established 10b5-1 plan. This type of transaction is generally not indicative of new material information and is often for personal financial planning. Therefore, it does not provide a strong basis for a 'buy' or 'sell' recommendation, suggesting a 'hold' position is appropriate based solely on this filing.
Keywords
VICOR CORP, VICR, Form 4, insider trading, stock options, 10b5-1 plan, director transactions, share sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.